Literature DB >> 1534823

Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen.

L I Zhang1, D R Martin, W P Fung-Leung, H S Teh, R G Miller.   

Abstract

It has been well established that T cell tolerance to self Ag occurs primarily via clonal deletion of immature thymocytes in the thymus. Evidence also exists that there are additional mechanisms operative on mature T cells for establishing and maintaining tolerance in the periphery. To follow the fate of mature Ag-specific T cells in vivo, we used female transgenic mice, which contain a large population of male H-Y Ag-specific T cells that can be identified by immunostaining with mAb directed against CD8 and the transgenic TCR. H-Y Ag was introduced into these mice by injecting Ag-bearing male lymphocytes using conditions known to induce CTL precursor response reduction. The number of Ag-reactive CD8+ transgenic T cells in the periphery started to decrease after 2 days of in vivo exposure to male Ag. Decline was maximum (up to 80% of total) by 7 days, and stayed at this level for at least 6 wk. CD4+ cells and those CD8+ cells that did not carry the transgenic TCR were not affected. Most or all of the remaining Ag-reactive CD8+ cells in the periphery were fully responsive when stimulated by male Ag in vitro. Maturation of transgenic T cells in the thymus of injected mice remained the same as that of control animals. Our data provide direct evidence that mature Ag-reactive CD8+ cells are susceptible to clonal deletion in the periphery when exposed to the Ag in vivo. These findings suggest the presence of two types of APC in the periphery: stimulatory APC (e.g., macrophages and dendritic cells) required for initiating an active immune response; and functionally deleting APC (or veto cells) capable of deleting mature T lymphocytes that recognize Ag presented on their surface. Functionally deleting APC that present self Ag to peripheral T cells may provide a fail-safe mechanism against autoreactive cells that escaped deletion during differentiation in the thymus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Authors:  U D Staerz; Y Qi
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

Review 2.  Molecular and cellular mechanisms of donor cell-induced tolerance.

Authors:  James F George; Leonik Ahumada; Ailing Lu
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression.

Authors:  Meixiao Long; Aaron M Slaiby; Adam T Hagymasi; Marianne A Mihalyo; Alexander C Lichtler; Steven L Reiner; Adam J Adler
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

4.  CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Authors:  Oren Milstein; David Hagin; Assaf Lask; Shlomit Reich-Zeliger; Elias Shezen; Eran Ophir; Yaki Eidelstein; Ran Afik; Yaron E Antebi; Michael L Dustin; Yair Reisner
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

5.  Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.

Authors:  M A Alexander-Miller; G R Leggatt; A Sarin; J A Berzofsky
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 6.  Immunologic tolerance in renal transplantation.

Authors:  D A Shoskes
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 7.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

8.  Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.

Authors:  S A Litherland; X T Xie; A D Hutson; C Wasserfall; D S Whittaker; J X She; A Hofig; M A Dennis; K Fuller; R Cook; D Schatz; L L Moldawer; M J Clare-Salzler
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

9.  Susceptibility of neonatal T cells and adult thymocytes to peripheral tolerance to allogeneic stimuli.

Authors:  Fábio B do Canto; Celso Lima Junior; Ivan A Teixeira; Maria Bellio; Alberto Nóbrega; Rita Fucs
Journal:  Immunology       Date:  2008-05-03       Impact factor: 7.397

10.  The surprising kinetics of the T cell response to live antigenic cells.

Authors:  Aaron J Tyznik; Michael J Bevan
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.